Recent Advances in Hepatic Transplantation at the University of Pittsburgh

Overview

Journal Clin Transpl

Specialty General Surgery

Date 1993 Jan 1

PMID 7522528

Citations 1

Authors

K Abu-Elmagd

O Bronsther

A Jain

W Irish

H Ramos

I R Marino

F DODSON

R Selby

H Doyle

H Furukawa

Affiliations

Soon will be listed here.

Abstract

FK506 undoubtedly improved the survival advantage of hepatic allotransplantation. Hepatic-intestinal and multivisceral transplantation has also become a feasible therapy for patients with combined intestinal and liver failure. With better understanding of the immunologic and metabolic aspects of allo- and xenotransplantation, further clinical attempts to transplant animal organs to humans may be considered with the hope for a better outcome in the very near future.

Citing Articles

Causes of late mortality in pediatric liver transplant recipients.

Sudan D, Shaw Jr B, Langnas A Ann Surg. 1998; 227(2):289-95.

PMID: 9488529 PMC: 1191248. DOI: 10.1097/00000658-199802000-00020.

References

Alessiani M, Kusne S, Martin F, Fung J, Jain A, Todo S . Infections with FK 506 immunosuppression: preliminary results with primary therapy. Transplant Proc. 1990; 22(1):44-6. PMC: 2903870. View

Alessiani M, Cillo U, Fung J, Irish W, Abu-Elmagd K, Jain A . Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc. 1993; 25(1 Pt 1):628-34. PMC: 2996874. View

Starzl T, Demetris A, Trucco M, Ricordi C, Ildstad S, Terasaki P . Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med. 1993; 328(11):745-9. PMC: 2963442. DOI: 10.1056/NEJM199303183281101. View

Todo S, Fung J, Tzakis A, Demetris A, Jain A, Alessiani M . One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc. 1991; 23(1 Pt 2):1397-402. View

Murase N, Demetris A, Matsuzaki T, Yagihashi A, Todo S, Fung J . Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery. 1991; 110(1):87-98. PMC: 2975982. View

Green M, Tzakis A, Reyes J, Nour B, Todo S, Starzl T . Infectious complications of pediatric liver transplantation under FK 506. Transplant Proc. 1991; 23(6):3038-9. PMC: 2964130. View

Todo S, Demetris A, Van Thiel D, Teperman L, Fung J, Starzl T . Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology. 1991; 13(4):619-26. PMC: 2972630. View

Slavin S, Strober S, Fuks Z, Kaplan H . Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med. 1977; 146(1):34-48. PMC: 2180728. DOI: 10.1084/jem.146.1.34. View

. Second International Workshop on FK 506. A potential breakthrough in immunosuppression: clinical implications. October 31, 1989, Barcelona, Spain. Proceedings. Transplant Proc. 1990; 22(1):5-113. View

10.

Jain A, Fung J, Todo S, Alessiani M, Takaya S, Abu-Elmagd K . Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc. 1991; 23(1 Pt 2):928-30. PMC: 2967371. View

11.

Jain A, Venkataramanan R, Lever J, Warty V, Fung J, Todo S . FK506 and pregnancy in liver transplant patients. Transplantation. 1993; 56(6):1588-9. PMC: 2954619. View

12.

Shah G, Demetris A, Irish W, Scheffel J, Mimms L, Van Thiel D . Frequency and severity of HCV infection following orthotopic liver transplantation. Effect of donor and recipient serology for HCV using a second generation ELISA test. J Hepatol. 1993; 18(3):279-83. DOI: 10.1016/s0168-8278(05)80270-3. View

13.

Reyes J, Tzakis A, Green M, Nour B, Nalesnik M, Van Thiel D . Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. Transplant Proc. 1991; 23(6):3044-6. PMC: 2975614. View

14.

Alessiani M, Kusne S, Martin M, Jain A, Abu-Elmagd K, Moser J . Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc. 1991; 23(1 Pt 2):1501-3. PMC: 2957095. View

15.

Starzl T, Demetris A, Murase N, Thomson A, Trucco M, Ricordi C . Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today. 1993; 14(6):326-32. PMC: 2979321. DOI: 10.1016/0167-5699(93)90054-o. View

16.

Murase N, Kim D, Todo S, Cramer D, Fung J, Starzl T . Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. Transplant Proc. 1990; 22(1):74-5. PMC: 2903852. View

17.

Jain A, Fung J, Venkataramanan R, Todo S, Alessiani M, Starzl T . FK 506 dosage in human organ transplantation. Transplant Proc. 1990; 22(1):23-4. PMC: 2903883. View

18.

Starzl T, Demetris A, Murase N, Ildstad S, Ricordi C, Trucco M . Cell migration, chimerism, and graft acceptance. Lancet. 1992; 339(8809):1579-82. PMC: 2950640. DOI: 10.1016/0140-6736(92)91840-5. View

19.

Eghtesad B, Bronsther O, Irish W, Casavilla A, Abu-Elmagd K, Van Thiel D . Disease gravity and urgency of need as guidelines for liver allocation. Hepatology. 1994; 20(1 Pt 2):56S-62S. PMC: 2962596. DOI: 10.1016/0270-9139(94)90274-7. View

20.

Abu-Elmagd K, Fung J, Alessiani M, Jain A, Venkataramanan R, Warty V . The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation. 1991; 52(1):71-7. PMC: 2978661. DOI: 10.1097/00007890-199107000-00015. View